- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
NIH Official Denies Any Deal With Disciplined Psychiatrist
16 June 2010 11:11 am
A National Institutes of Health institute director says on his blog that there was no "quid pro quo relationship" regarding employment opportunities between him and Charles Nemeroff, a former Emory University psychiatrist who broke federal rules on reporting drug-company income.
Thomas Insel, head of the National Institute of Mental Health, wrote yesterday that a recent story in The Chronicle of Higher Education "suggested incorrectly" that Nemeroff had helped Insel to become director of Emory's Yerkes National Primate Research Center in 1994. In 2009, after Nemeroff applied for a job at the University of Miami, Insel also said he spoke with the dean of the university's medical school "simply to describe the facts" that a 2-year ban imposed by Emory in December 2008 on applying for NIH grants would not follow Nemeroff if he moved to Miami, which Nemeroff did in December 2009. However, Insel says he will recuse himself from future NIH matters involving Nemeroff to avoid any further misperceptions.